课题基金 / 基金详情

CORE--Molecular Biology and Vector Core

CORE--Molecular Biology and Vector Core
CORE--分子生物学和载体核心
批准号:
6990180
负责人:
SVEND O FREYTAG
金额:
$30.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2009-07-31

项目摘要

项目成果

SVEND O FREYTAG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Molecular Biology and Vector Core (Core B) will have the following functions: 1) maintain inventory of recombinant DNA vectors, 2)perform large-scale plasmid preps, 3) perform plasmid cloning, 4) perform HEK 293 cell transfections, 5) perform large-scale adenovirus preps, 6) characterize recombinant adenoviruses (laboratory and GMP grade), 7) analyze potency of adenovirus following each patient injection, 8) monitor presence of adenoviral DNA in patient's blood using PCR/Southern blot assay. The Molecular Biology and Vector Core will provide laboratory grade, CsCl gradient-purified adenovirus to Projects 1 and 2. Clinical grade (GMP) adenovirus will be manufactured at the Baylor Gene Vector Laboratory. Clinical grade virus will be characterized extensively in the Molecular Biology and Vector Core before it is used in Project 3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene Therapy and Radiation Therapy for Prostate Cancer
  • 批准号:
    8401887
  • 项目类别:
  • 资助金额:
    $28.57万
  • 财政年份:
    2012
  • 负责人:
    SVEND O FREYTAG
  • 依托单位:
Gene Therapy and Radiation Therapy for Prostate Cancer
  • 批准号:
    8599755
  • 项目类别:
  • 资助金额:
    $29.49万
  • 财政年份:
    2012
  • 负责人:
    SVEND O FREYTAG
  • 依托单位:
Gene Therapy and Radiation Therapy for Prostate Cancer
  • 批准号:
    8239143
  • 项目类别:
  • 资助金额:
    $30.4万
  • 财政年份:
    2012
  • 负责人:
    SVEND O FREYTAG
  • 依托单位:
Gene Therapy and Radiation Therapy for Prostate Cancer
  • 批准号:
    8984293
  • 项目类别:
  • 资助金额:
    $27.36万
  • 财政年份:
    2012
  • 负责人:
    SVEND O FREYTAG
  • 依托单位:
海外基金